Skip to content

Clinical trials

Completed Alzheimer Disease trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Brazil Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20091
20104
20122
20131
20145
20151
20163
20192
20213
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
H. Lundbeck A/S3
Brasilia University Hospital2
Eli Lilly and Company2
Alnylam Pharmaceuticals1
Associacao Fundo de Incentivo a Psicofarmcologia1
Deivis de Oliveira guimaraes1
Eidos Therapeutics, a BridgeBio company1
Federal University of Bahia1
Federal University of Latin American Integration1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease29
Amyloid Neuropathies, Familial5
Amyloidosis5
Cardiomyopathies2
Dementia2
Parasomnias2
Polyneuropathies2
Sleep Initiation and Maintenance Disorders2
Sleep Wake Disorders2
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.